美国的神经血管栓塞设备市场评估:各产品，疾病病理，各终端用户，各地区，机会，机会及预测，2018～2032年

美国医疗保健服务和保险覆盖范围的改善为治疗神经血管患者提供了更强大的基础设施。预计 2024 年美国神经栓塞设备市场价值将达到 3.862 亿美元，预计 2025 年至 2032 年期间的复合年增长率为 8.51%。由于久坐的生活方式导致脑动脉出血和异常盛行率上升、脑动脉瘤和动静脉畸形 (AVM) 病例增加是神经血管栓塞装置需求激增的主要原因。此外，推动美国神经栓塞设备市场成长的因素包括老年人口的增加、高血压患者数量的增加以及新型神经栓塞设备的引入。

称为神经栓塞装置的血管内植入物旨在永久切断脑动脉瘤和动静脉畸形的血液供应。

目录

第1章 调查手法

第2章 计划的范围和定义

第3章 摘要整理

第4章 美国的神经血管栓塞设备市场展望，2018年～2032年

• 市场规模与预测
  • 各金额
  • 各数量
• 市场占有率与预测
  • 各产品
    • 动脉瘤夹
    • 液体栓塞系统
    • 栓塞线圈
    • 血流转换支架
    • 囊内血流阻碍要素
  • 疾病病理
    • 缺血性中风
    • 脑动脉瘤
    • 颈动脉狭窄症
    • 动静脉畸形及瘘管
    • 其他的病
  • 各终端用户
    • 医院
    • 门诊病人手术中心
    • 专门诊所
    • 其他
  • 地区
    • 东北部
    • 西南部
    • 西部
    • 东南部
    • 中西部
  • 市场占有率(%)各企业，2024年

第5章 市场製图，2024年

• 各产品
• 疾病病理
• 各终端用户
• 各地区

第6章 宏观环境和产业结构

• 供给需求分析
• 进口出口分析
• 价值链分析
• 神经血管栓塞设备市场PESTEL分析
  • 政治要素
  • 经济系统
  • 社会影响
  • 技术的进步
  • 对环境的影响
  • 法律合规与监管政策（包括法定机构）
• 波特的五力分析
  • 供应商的力量
  • 买方势力
  • 替代威胁
  • 新加入厂商的威胁
  • 竞争企业间的敌对关係

第7章 市场动态

• 成长促进因素
• 阻碍成长的要素

第8章 法规结构和革新

• 临床试验
• 专利形势
• FDA核准
• 产品革新/新兴技术

第9章 案例研究

第10章 价格分析

第11章 主要企业的形势

• 市场领导前五名公司的竞争矩阵
• 前五名市场领导的市场收益分析(%、2024年)
• 併购/合资（如适用）
• SWOT 分析（针对 5 家市场公司）

第12章 主要企业的展望

• Microport Scientific Corporation
• 公司概要
• 主要经营团队
• 产品和服务
• 财务状况(如报告)
• 主要市场的着重和地理存在感
• 最近的趋势
• Integra LifeSciences Corporation
• Medtronic Plc
• Terumo Corporation(MicroVention, Inc)
• B. Braun Melsungen AG
• Penumbra, Inc
• Stryker Corporation
• Kaneka Medical Products
• Johnson &Johnson(Cerenovous)
• Codman &Shrutleff, Inc.

上述公司尚未根据市场占有率保留订单，并且可能根据研究工作期间可用的资讯而发生变化。

第14章 策略性建议

第15章 关于调查公司·免责声明

Improved access to healthcare services and insurance coverage in the United States have resulted in a more robust infrastructure for treatment of neurovascular patients. The United States Neurovascular Embolization Devices market was valued at 386.20 million in 2024 and is projected to be growing at a CAGR of 8.51% from 2025 to 2032. The increasing prevalence of hemorrhages & anomalies in cerebral arteries, rising cases of brain aneurysms, and arteriovenous malformations (AVMs) due to sedentary lifestyles are the main causes of surge in demand for neurovascular embolization devices. In addition, factors driving the growth of the United States neurovascular embolization devices market includes increasing geriatric population, increasing number of patients with hypertension and the introduction of novel neurovascular embolization devices.

An intravascular implant called a neurovascular embolization device is designed to permanently cut off blood supply to brain aneurysms and arteriovenous malformations.

Increasing Number of Patients with Cerebral Aneurysm Driving the Market

In recent years, there has been an increasing number of cerebral aneurysm patients in the United States, which has led to a growing demand for neurovascular embolization devices in the market. The market for these devices has been growing as more patients are diagnosed with cerebral aneurysms and seek treatment. Ruptured brain aneurysm affects around 6.7 million people in the United States, or one in every fifty people. Women above the age 55, have a higher risk of cerebral aneurysm rupture as compared to men.

Technological Advancements Accelerating the Market Growth

Technological advancements have made it possible to identify a size and shape of aneurysm. One major advancement is the development of new materials for embolization coils and flow diverters. These devices are used to block blood flow to abnormal blood vessels in the brain, and the new materials provide better visibility and control during the procedure. Additionally, there has been increased use of robotic systems for neurovascular procedures, which provide greater precision and control during the procedure.

Increasing Research Activities Support Market Expansion

The continuous emphasis on research activities has resulted in the creation of more sophisticated embolization devices, such as flow-diverting stents and liquid embolics, that have made the treatment of aneurysms and arteriovenous malformations more accessible. This improves the outcomes of the patients and enhances the success rate of neurovascular interventions. Increased investments in research enables a higher number of clinical trials and thus accelerates the regulatory approval process for new devices. Additionally, by focusing on research activities, medical technology companies are also able to ensure the development and availability of advanced technologies for effective management and treatment of chronic conditions.

For instance, in January 2023, Fluidx Medical Technology, Inc. release findings from their in vivo research for the Impass embolic device for middle meningeal artery (MMA) embolization for treating chronic subdural hematomas on the brain's surface. The device utilizes a low-viscosity, aqueous-based solution that solidifies into a durable embolus upon delivery. This technology aims to improve safety and efficacy during embolization procedures, potentially leading to better patient outcomes and increased adoption by healthcare providers, thus, supporting the market's expansion.

Cerebral Embolization and Aneurysm Coiling Devices Account for Majority of Market Share

Cerebral embolization and aneurysm coiling devices led the neurovascular device market. More than 40% of the market was accounted for cerebral embolization and aneurysm coiling devices, which are widely used in the treatment of aneurysms and strokes. Rising healthcare costs, increased R&D spending, and rising frequency of neurological diseases such as brain aneurysms, stroke, and arteriovenous malformations (AVMs) are few factors driving the market expansion.

Impact of COVID-19 on the United States Neurovascular Embolization Devices Market

The pandemic had a significant impact on the United States Neurovascular Embolization Device Market. The market has witnessed a decline in growth due to the pandemic's impact on healthcare facilities' operations, as well as a reduction in demand for non-urgent medical procedures. Additionally, the disruption of supply chains caused by the pandemic has led to delays in the production and distribution of neurovascular embolization devices, further impacting the market's growth. The market bounced back to pre-pandemic levels after upliftment of lockdown.

Impact of Russia-Ukraine War on the United States Neurovascular Embolization Devices Market

The Russia-Ukraine war did not have a significant impact on the United States neurovascular embolization market. Although, the war disrupted the trade dynamics such as demand-supply, pricing variances, impact on import/export and trading activities between United States, Russia, and Ukraine. Economic sanctions imposed by United States impacted the export of devices to Russia.

Key Players Landscape and Outlook

The market for neurovascular devices is competitive and is dominated by major players. The key players in the market are Terumo Corporation, Johnson & Johnson, and Medtronic Plc, Microport Scientific Corporation, Integra Life Sciences Corporation, Penumbra Inc and many others.

In 2021, Medtronic recalled two of its transcatheter devices intended to seal brain aneurysms: the Pipeline Flex Embolization Device and the Pipeline Flex Embolization Device with Shield Technology. The wire and tubes fractured and broke down when the delivery systems were used to place, remove, or relocate the stent within a patient.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. United States Neurovascular Embolization Devices Market Outlook, 2018-2032F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Aneurysm Clips
    • 4.2.1.2. Liquid Embolic Systems
    • 4.2.1.3. Embolization Coils
    • 4.2.1.4. Flow Diversion Stents
    • 4.2.1.5. Intrasaccular Flow Disruptors
  • 4.2.2. By Disease Pathology
    • 4.2.2.1. Ischemic Strokes
    • 4.2.2.2. Cerebral Aneurysm
    • 4.2.2.3. Carotid Artery Stenosis
    • 4.2.2.4. Arteriovenous Malformations and fistulas
    • 4.2.2.5. Other Diseases
  • 4.2.3. By End User
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Ambulatory Surgical Centers
    • 4.2.3.3. Specialty Clinics
    • 4.2.3.4. Others
  • 4.2.4. Region
    • 4.2.4.1. Northeast
    • 4.2.4.2. Southwest
    • 4.2.4.3. West
    • 4.2.4.4. Southeast
    • 4.2.4.5. Midwest
  • 4.2.5. By Company Market Share (%), 2024

5. Market Mapping, 2024

• 5.1. By Product
• 5.2. By Disease Pathology
• 5.3. By End User
• 5.4. By Region

6. Macro Environment and Industry Structure

• 6.1. Supply Demand Analysis
• 6.2. Import Export Analysis
• 6.3. Value Chain Analysis
• 6.4. PESTEL Analysis of the Neurovascular Embolization Devices Market
  • 6.4.1. Political Factors
  • 6.4.2. Economic System
  • 6.4.3. Social Implications
  • 6.4.4. Technological Advancements
  • 6.4.5. Environmental Impacts
  • 6.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 6.5. Porter's Five Forces Analysis
  • 6.5.1. Supplier Power
  • 6.5.2. Buyer Power
  • 6.5.3. Substitution Threat
  • 6.5.4. Threat from New Entrant
  • 6.5.5. Competitive Rivalry

7. Market Dynamics

• 7.1. Growth Drivers
• 7.2. Growth Inhibitors

8. Regulatory Framework and Innovation

• 8.1. Clinical Trials
• 8.2. Patent Landscape
• 8.3. FDA Approvals
• 8.4. Product Innovations/Emerging Technologies

9. Case Studies

10. Pricing Analysis

11. Key Players Landscape

• 11.1. Competition Matrix of Top Five Market Leaders
• 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2024)
• 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 11.4. SWOT Analysis (For Five Market Players)

12. Key Players Outlook

• 12.1. Microport Scientific Corporation
  • 12.1.1. Company Details
  • 12.1.2. Key Management Personnel
  • 12.1.3. Products & Services
  • 12.1.4. Financials (As reported)
  • 12.1.5. Key Market Focus & Geographical Presence
  • 12.1.6. Recent Developments
• 12.2. Integra LifeSciences Corporation
• 12.3. Medtronic Plc
• 12.4. Terumo Corporation (MicroVention, Inc)
• 12.5. B. Braun Melsungen AG
• 12.6. Penumbra, Inc
• 12.7. Stryker Corporation
• 12.8. Kaneka Medical Products
• 12.9. Johnson & Johnson (Cerenovous)
• 12.10. Codman & Shrutleff, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Neurovascular Embolization Devices Market, By Value, In USD Million, 2018 - 2032F
• Figure 2. United States Neurovascular Embolization Devices Market, By Volume, In Thousand Units, 2018 - 2032F
• Figure 3. United States Neurovascular Embolization Devices Market Share, By Product, In USD Million, 2018 - 2032F
• Figure 4. United States Neurovascular Embolization Devices Market Share, By Product, In Thousand Units, 2018 - 2032F
• Figure 5. United States Neurovascular Embolization Devices Market Share, By Disease Pathology, In USD Million, 2018 - 2032F
• Figure 6. United States Neurovascular Embolization Devices Market Share, By Disease Pathology, In Thousand Units, 2018 - 2032F
• Figure 7. United States Neurovascular Embolization Devices Market Share, By End User, In USD Million, 2018 - 2032F
• Figure 8. United States Neurovascular Embolization Devices Market Share, By End User, In Thousand Units, 2018 - 2032F
• Figure 9. United States Neurovascular Embolization Devices Market Share, By Region, In USD Million, 2018 - 2032F
• Figure 10. United States Neurovascular Embolization Devices Market Share, By Region, In Thousand Units, 2018 - 2032F
• Figure 11. By Product Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 12. By Disease Pathology Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 13. By End User Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 14. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024